[ad_1] France – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2022 and provided an update on key clinical and preclinical achievements, on…
Tag: Immunotherapeutics
OSE Immunotherapeutics Reports Full Year 2022 Financial Results and Provides Business Strategy Update
[ad_1] OSE Immunotherapeutics Reports Full Year 2022 Financial Results … WV News [ad_2] Source link